Bennett R M, Kotzin B L, Merritt M J
Division of Arthritis and Rheumatic Diseases, Oregon Health Sciences University, Portland 97201.
J Exp Med. 1987 Oct 1;166(4):850-63. doi: 10.1084/jem.166.4.850.
The ability of sera from patients with SLE and similar connective tissue diseases to induce dysfunction of the receptor for DNA was studied. All SLE and MCTD sera studied resulted in marked inhibition of DNA receptor binding. Furthermore, the sera from a subgroup of patients with other rheumatic diseases and a surprisingly high percentage of asymptomatic relatives of SLE patients exhibited a similar effect. The humoral factors causing this defect were shown to be of at least three reactivities: (a) antibodies to DNA, (b) antibodies to histones, and (c) antibodies to the DNA receptor itself. The reactivity of anti-DNA and antihistone antibodies is dependent upon intact cell-surface DNA, and reconstitution experiments suggest that antihistone antibodies are reactive with histones complexed to this DNA, which in turn is bound to the DNA receptor. Cells with an antibody-induced DNA receptor defect are unable to bind DNA; the subsequent inability to degrade DNA may have important consequences in diseases such as SLE in which DNA-anti-DNA immune complexes are of pathogenetic significance.
对系统性红斑狼疮(SLE)及类似结缔组织病患者血清诱导DNA受体功能障碍的能力进行了研究。所有研究的SLE和混合性结缔组织病(MCTD)血清均导致DNA受体结合显著抑制。此外,其他风湿性疾病患者亚组的血清以及SLE患者中比例惊人的无症状亲属血清也表现出类似效应。导致这种缺陷的体液因子至少具有三种反应性:(a)抗DNA抗体,(b)抗组蛋白抗体,以及(c)抗DNA受体自身抗体。抗DNA和抗组蛋白抗体的反应性依赖于完整的细胞表面DNA,重建实验表明抗组蛋白抗体与与此DNA复合的组蛋白发生反应,而该DNA又与DNA受体结合。具有抗体诱导的DNA受体缺陷的细胞无法结合DNA;随后无法降解DNA可能在诸如SLE等疾病中产生重要后果,在这些疾病中DNA-抗DNA免疫复合物具有致病意义。